Novavax (NVAX) Non-cash Items (2012 - 2020)

Novavax (NVAX) recorded quarterly Non-cash Items of $289073.0 in Q3 2020, down 69.67% quarter-over-quarter from $953073.0 in Q2 2020.

Novavax (NVAX) Non-cash Items (2012 - 2020) Analysis & Trends

Novavax's Non-cash Items history runs 3 years deep, the most recent figure standing at $289073.0 for Q3 2020.

In Q3 2020, Non-cash Items changed N/A year-over-year to $289073.0; the TTM figure through Sep 2020 stood at $289073.0 (changed N/A YoY), while the FY2019 annual figure was $1.0 million, changed N/A from the prior year.
Non-cash Items was $289073.0 for Q3 2020 at Novavax, down from $953073.0 in the prior quarter.
In the past five years, Non-cash Items ranged from a high of $1.1 million in Q1 2020 to a low of $289073.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Novavax	1.49 Bn	931.98 Mn	108.82 Mn

Download Data